ALXN - Alexion Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue4,131,2003,551,1003,084,1002,604,000
Cost of Revenue368,500302,100258,300233,100
Gross Profit3,762,7003,249,0002,825,8002,370,900
Operating Expenses
Research Development730,300862,100757,200709,500
Selling General and Administrative1,092,4001,083,500953,000862,600
Non Recurring----
Others----
Total Operating Expenses2,511,3002,567,8002,290,7001,921,800
Operating Income or Loss1,619,900983,300793,400682,200
Income from Continuing Operations
Total Other Income/Expenses Net-1,377,700-435,500-217,200-184,100
Earnings Before Interest and Taxes1,619,900983,300793,400682,200
Interest Expense-98,200-98,400-96,900-47,800
Income Before Tax242,200547,800576,200498,100
Income Tax Expense164,600104,500176,800353,700
Minority Interest----
Net Income From Continuing Ops77,600443,300399,400144,400
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income77,600443,300399,400144,400
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares77,600443,300399,400144,400